Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

OXALIPLATIN

OXALIPLATIN

Standard Dose
200MG/40ML (5MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview OXALIPLATIN is listed in Drugs@FDA under application 207474 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient OXALIPLATIN Form and strength INJECTABLE;INTRAVENOUS - 200MG/40ML (5MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2026-03-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview OXALIPLATIN is listed in Drugs@FDA under application 207474 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient OXALIPLATIN Form and strength INJECTABLE;INTRAVENOUS - 200MG/40ML (5MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2026-03-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.